Announcement on Obtaining Government Subsidies
Filed with SSE · · 1 page · Chinese
Jiangsu Aidea Pharmaceutical Group Co., Ltd. on 6ix
Earlier from Jiangsu Aidea Pharmaceutical
- Announcement on Re-signing Tripartite Supervision Agreement over Deposit in Special Account of Raised Funds after Changing Sponsor Institution
- Notice on Convening the 1st Extraordinary General Meeting in 2026
- Announcement on Voluntary Disclosure of Receipt of Approval Notice for the Listing Application of Darunavir Active Pharmaceutical Ingredient
- Science and Technology for People's Well-being - Achievement of Enterprises on SSE STAR Market and Its Empowerment of People's Livelihood Conference
- Announcement on Progress in Acquisition of Minority Shareholders' Stock Rights of a Holding Subsidiary
Later from Jiangsu Aidea Pharmaceutical
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial for ADC119 Tablets
- Announcement on Voluntary Disclosure of Obtaining of Drug Registration Approval for Darunavir Tablets
- Announcement on Cancellation of Certain Dedicated Settlement Accounts for Wealth Management Products Purchased with Raised Funds
- Announcement on Use of Own Funds, Bank Acceptance Bills and Other Methods to Pay Funds Required for Raised Fund Investment Projects and Equivalent Replacement with Raised Funds
Follow Jiangsu Aidea Pharmaceutical into a list and get an email when it puts out news.
Follow Jiangsu Aidea Pharmaceutical